MAIA Biotechnology News

MAIA Biotechnology Shares Hit 52-Week High After Director Stock Purchase

By Chris Wack MAIA Biotechnology shares hit their 52-week high Monday after it said that independent director Stan Smith made an individual purchase of 147,000 shares, and warrants for 147,000 shares

WSJApr 30 01:04

NYSE American New 52-Week Highs And Lows

New Highs 7 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Air Industries Group AIRI 7.24 71,596 Ar

Dow JonesApr 29 22:20

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement

Dr. Smith has participated in every MAIA funding round CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company de

BusinesswireApr 29 20:08

Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing

Stan Smith, Director, on April 25, 2024, executed a purchase for 147,492 shares in Maia Biotechnology (MAIA) for $299,409. Following the Form 4 filing with the SEC, Smith has control over a total of 1

MT NewswiresApr 27 05:37

MAIA Biotechnology Announces $1.00 Million Private Placement

MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements

BusinesswireApr 23 20:51

NYSE American Net Change Percentage Gainers & Losers

GAINERS COMPANY SYMBOL LAST CHANGE PERCENT VOLUME ------- ------ ---- ------ ------- ------ CPI Aerost

Dow JonesApr 9 05:45

MAIA Biotechnology to Present at Two Investor Conferences in April 2024

MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that Chairman and Chief Executive Officer Vlad

BusinesswireApr 5 20:01

MAIA Biotechnology Boosts CEO Jeffrey Himmelreich's Salary

TipRanksApr 3 04:22

MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero

Company recognizes significant support by board members in recent private placement MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted

BusinesswireMar 29 03:00

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement

Five independent members of MAIA's Board of Directors purchased shares in the offering MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted

BusinesswireMar 27 03:00

MAIA Biotechnology Announces $1.33 Million Private Placement

MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements

BusinesswireMar 26 20:01

MAIA Biotechnology Increased Maximum Aggregate Offering Price Of Shares Of Common Stock, Issuable Under At Market Offering Agreement

MAIA Biotechnology Increased Maximum Aggregate Offering Price Of Shares Of Common Stock, Issuable Under At Market Offering Agreement

BenzingaMar 26 04:11

CGC, CYTO and IDN Are Among Mid-day Movers

Seeking AlphaMar 26 01:25

MAIA Biotechnology at Risk of NYSE Delisting Over Equity Shortfalls

TipRanksMar 23 14:02

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement

Dr. Smith has participated in every MAIA funding round MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA," the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today

BusinesswireMar 23 03:00

MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to Its Scientific Advisory Board

Acclaimed academic researcher has led 40+ multicenter phase 2 and phase 3 clinical studies MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing

BusinesswireMar 22 03:00

Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA)

Yahoo FinanceMar 16 13:49

Maia Biotechnology Director Buys $8.1k in Company Shares

InvestingMar 16 07:06

MAIA Biotechnology up 3%, Raises $2.9MM via Private Placement

Seeking AlphaMar 14 14:39

MAIA Biotechnology Shares Halted On Code News Pending

MAIA Biotechnology Shares Halted On Code News Pending

BenzingaMar 14 01:33